Globally we are seeing an aging population with an increasing prevalence of diabetes and metabolic syndrome. Consequently, the number of patients with critical limb ischemia (CLI) is rising. Patients with CLI are at risk for both limb loss and premature death. Refinements in endovascular therapy have led to a paradigm shift in revascularization strategy in treating these complex patients.
Endovascular treatment of CLI is undergoing immense growth due to innovations in endovascular therapy. We are seeing enormous advances in both devices and procedure techniques. Patient outcomes are not all equal nor satisfactory. Increasingly we are seeing that the best outcomes occur in Centers of Excellence with dedicated limb salvage experts.
This article between 2 leading CLI Experts focuses on the inevitable movement towards identifying high quality operators and centers of excellence.
The SFICV EFUZEN study is the largest prospective study reporting sexual desire and function after uterine fibroid embolization (UFE).
This paper uses data from the Vascular Quality Initiative (VQI) database to compare outcomes in patients undergoing a below the...
Pedal loop revascularization procedures are the last resort for patients with no other options for saving their limb.